 |
|
|
| |
Pharmacodynamics, Safety, and Pharmacokinetics of BMS-663068, a Potentially First-in-Class Oral HIV Attachment Inhibitor
|
| |
| |
Reported by Jules Levin
Conference on Retroviruses and Opportunistic Infections. February 27 -March 2, 2011Boston, MAAbstract 49
Richard Nettles and Dirk Schurmann, Li Zhu, Michele Stonier,Shu-Pang Huang, Caly Chien, Mark Krystal,Megan Wind-Rotolo, Richard Bertz and Dennis Grasela
In today's opening session where this slide talk was presented the first talk was on SB728, the zinc finger therapy study where initial results reported increased CD4 by 100, I think study was done in naïves and experienced and more evaluations will be conducted to see what other affects this therapy has, where they take out blood, treat it and reinfuse, frankly I'm not very impressed.
|
| |
|
|
|
|
|
